Skip to content

News

Recombinetics Announces Collaboration with Mayo Clinic to Develop the First-Ever Swine Models of Osteogenesis Imperfecta

Read More »

Company Statement & FAQs on Plasmid Insertion Found in First Gene-Edited Bull

Read More »

Precision Breeding’s New Horizons

Read Story Here

Recombinetics Awarded National Institutes of Health Funding to Develop Genetically Engineered Swine Model of Glioblastoma, the Deadliest Type of Brain Tumor

Read More »

The Alliance to End Surgical Castration of Swine Announces Precision Breeding Successes

Read More »

Acceligen and Kheiron-Biotech Announce Joint Projects Focused on Precision Breeding

Read More »

From TALENs to the Table

Read Story Here

Recombinetics Names Dr. Tad Sonstegard the First Chief Executive Officer of Its Wholly-Owned Subsidiary, Acceligen

Read More »

A More Humane Livestock Industry, Brought To You By CRISPR.

Read Story Here